Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel J S Rubin

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Current Topics in Medicinal Chemistry|July 18, 2018
Cyclic Peptides for Protein-Protein Interaction TargetsNir Qvit, Samuel J S Rubin
Current Topics in Medicinal Chemistry|December 10, 2020
Peptide Therapeutics: Scientific Approaches, Current Development Trends, and Future DirectionsNir Qvit, Samuel J S Rubin
Current Topics in Medicinal Chemistry|October 22, 2020
Engineering "Antimicrobial Peptides" and Other Peptides to Modulate Protein-Protein Interactions in CancerSamuel J S Rubin, Nir Qvit
Current Topics in Medicinal Chemistry|May 19, 2018
Backbone-Cyclized Peptides: A Critical ReviewSamuel J S Rubin, Nir Qvit
The American Journal of Gastroenterology|November 30, 2023
Looking to Future Applications of Large Language ModelsXichong Liu, Samuel J S Rubin, Stephan Rogalla
World Journal of Gastrointestinal Oncology|August 30, 2021
Immune checkpoint inhibitor-mediated colitis in gastrointestinal malignancies and inflammatory bowel diseaseAlexa R Weingarden, Samuel J S Rubin, John Gubatan
International Journal of Molecular Sciences|December 23, 2023
An Update on Protein Kinases as Therapeutic Targets-Part II: Peptides as Allosteric Protein Kinase C Modulators Targeting Protein-Protein InteractionsMulate Zerihun, Samuel J S Rubin, Shmuel Silnitsky, et al.
International Journal of Molecular Sciences|December 23, 2023
An Update on Protein Kinases as Therapeutic Targets-Part I: Protein Kinase C Activation and Its Role in Cancer and Cardiovascular DiseasesShmuel Silnitsky, Samuel J S Rubin, Mulate Zerihun, et al.
Nature Reviews. Rheumatology|April 11, 2019
B cell checkpoints in autoimmune rheumatic diseasesSamuel J S Rubin, Michelle S Bloom, William H Robinson
World Journal of Clinical Cases|March 23, 2022
Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancySamuel J S Rubin, Tatiana Balabanis, John Gubatan, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Current Topics in Medicinal Chemistry|July 18, 2018
Cyclic Peptides for Protein-Protein Interaction TargetsNir Qvit, Samuel J S Rubin
Current Topics in Medicinal Chemistry|December 10, 2020
Peptide Therapeutics: Scientific Approaches, Current Development Trends, and Future DirectionsNir Qvit, Samuel J S Rubin
Current Topics in Medicinal Chemistry|October 22, 2020
Engineering "Antimicrobial Peptides" and Other Peptides to Modulate Protein-Protein Interactions in CancerSamuel J S Rubin, Nir Qvit
Current Topics in Medicinal Chemistry|May 19, 2018
Backbone-Cyclized Peptides: A Critical ReviewSamuel J S Rubin, Nir Qvit
The American Journal of Gastroenterology|November 30, 2023
Looking to Future Applications of Large Language ModelsXichong Liu, Samuel J S Rubin, Stephan Rogalla
World Journal of Gastrointestinal Oncology|August 30, 2021
Immune checkpoint inhibitor-mediated colitis in gastrointestinal malignancies and inflammatory bowel diseaseAlexa R Weingarden, Samuel J S Rubin, John Gubatan
International Journal of Molecular Sciences|December 23, 2023
An Update on Protein Kinases as Therapeutic Targets-Part II: Peptides as Allosteric Protein Kinase C Modulators Targeting Protein-Protein InteractionsMulate Zerihun, Samuel J S Rubin, Shmuel Silnitsky, et al.
International Journal of Molecular Sciences|December 23, 2023
An Update on Protein Kinases as Therapeutic Targets-Part I: Protein Kinase C Activation and Its Role in Cancer and Cardiovascular DiseasesShmuel Silnitsky, Samuel J S Rubin, Mulate Zerihun, et al.
Nature Reviews. Rheumatology|April 11, 2019
B cell checkpoints in autoimmune rheumatic diseasesSamuel J S Rubin, Michelle S Bloom, William H Robinson
World Journal of Clinical Cases|March 23, 2022
Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancySamuel J S Rubin, Tatiana Balabanis, John Gubatan, et al.
Pageof 4